Format

Send to

Choose Destination
See comment in PubMed Commons below
Pharmacogenomics. 2006 Oct;7(7):1095-107.

Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders.

Author information

  • 1Department of Biochemistry, University of Cambridge, Cambridge, CB2 1QW, UK. Jlg40@mole.bio.cam.ac.uk

Abstract

With the rise of systems biology, a number of approaches have been developed to globally profile a tier of organization in a cell, tissue or organism. Metabolomics is an approach that attempts to profile all the metabolites in a biological matrix. One of the major challenges of this approach, as with other 'omic' technologies, is that the metabolome is context-dependent and will vary with pathology, developmental stage and environmental factors. Thus, the possibility of globally profiling the metabolome of an organism is a genuine analytical challenge, as by definition this must also take into consideration all relevant factors that influence metabolism. Despite these challenges, the approach has already been applied to understand the metabolism in a range of animal models, and has more recently started to be projected into the clinical situation. In this review, the technologies currently being used in metabolomics will be assessed prior to examining their use to study diseases related to the metabolic syndrome, including Type II diabetes, obesity, cardiovascular disease and fatty liver disease.

PMID:
17054419
DOI:
10.2217/14622416.7.7.1095
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center